Angion Biomedica Corp Watch

from 10-Q 16 pages Indenture or similar

from 8-K 15 pages Senior Secured Convertible Promissory Note Due February 15, 2026

from 8-K 14 pages Elicio Therapeutics, Inc. Pre-Funded Warrant to Purchase Common Stock

from 8-K 13 pages Elicio Therapeutics, Inc. Warrant to Purchase Common Stock

from S-3 50 pages Elicio Therapeutics, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities

from S-3 51 pages Elicio Therapeutics, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities

from S-3 19 pages Angion Biomedica Corp. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Angion Biomedica Corp. Form of Debt Securities Warrant Agreement Angion Biomedica Corp. Form of Debt Securities Warrant Agreement

from S-3 21 pages Angion Biomedica Corp. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Angion Biomedica Corp. Form of Preferred Stock Warrant Agreement

from S-3 20 pages Angion Biomedica Corp. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Angion Biomedica Corp. Form of Common Stock Warrant Agreement

from S-3 53 pages Angion Biomedica Corp. Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities

from 10-K 5 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 10-K 5 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from S-1/A 2 pages N U M B E R Angion Biomedica Corp. Incorporated Under the Laws of the State of Delaware See Reverse for Certain Definitions C O M M O N S T O C K This Certifies That: Specimen - Not Negotiable Is the Owner of Fully Paid and Non-Assessable Shares of Common Stock of $0.01 Par Value Each of Angion Biomedica Corp. Transferable on the Books of the Corporation in Person or by Duly Authorized Attorney Upon Surrender of This Certificate Duly Endorsed or Assigned. This Certificate and the Shares Represented Hereby Are Subject to the Laws of the State of Delaware, and to the Certificate of Incorporation and Bylaws of the Corporation, as Now or Hereafter Amended. This Certificate Is Not Valid Until Countersigned by the Transfer Agent. Witness the Facsimile Seal of the Corporation and the Facsimile Signatures of Its Duly Authorized Officers. Countersigned: Dated: Philadelphia Stock Transfer, Inc. 2320 Haverford Rd., Suite 230, Ardmore, Pa 19003 Transfer Agent By: Authorized Signature Specimen Not Negotiable Secretary President & Chief Executive Officer Cusip03476j 107 Shares Cs

from S-1 27 pages Amended and Restated Registration Rights Agreement

from S-1 12 pages Broker Purchase Warrant Angion Biomedica Corp. Shares: Initial Exercise Date: , 2018 Issue Date: , 2018

from S-1 12 pages Angion Biomedica Corp. Convertible Promissory Note , 20

from S-1 11 pages Common Stock Purchase Warrant Angion Biomedica Corp. Warrant Shares: Initial Exercise Date: , 2018 Issue Date: , 2018

from DRS/A 12 pages Broker Purchase Warrant Angion Biomedica Corp. Shares: Initial Exercise Date: , 2018 Issue Date: , 2018

from DRS/A 12 pages Angion Biomedica Corp. Convertible Promissory Note December [ ], 2019

from DRS/A 11 pages Common Stock Purchase Warrant Angion Biomedica Corp. Warrant Shares: Initial Exercise Date: , 2018 Issue Date: , 2018